# Colorado MED Rules 2025 - Part 7 of 17

e in 
the prior four (4)two (2) calendar years during which the requesting Controlling Beneficial 
Owner or Passive Beneficial Owner that was licensed or disclosed was identified on the 
Licensee’s ownership structure on file with the Division. 
2. Applications provided by the Division in response to a request under this rule will not 
include supporting documents. For example, business records provided by the Division 
under this rule will not include leases, operating agreements, or premises diagrams. 
3. Business records provided to a Controlling Beneficial Owner, Passive Beneficial Owner 
that was licensed and disclosed, or authorized representative under this rule will only be 
provided in an electronic format and sent only to the Controlling Beneficial Owner, 
disclosed Passive Beneficial Owner, or to an individual with a valid authorization letter on 
file with the Division. 
4. Requests for records under this Rule must be accompanied by the fee required by Rule 
2-140. 
B. The Division will not provide any business records or provide business records to any person 
which could violate the obligation to maintain the confidentiality of documents and information 
provided by Applicants and Licensees to the State Licensing Authority as provided in Section 44-
10-204, C.R.S. 
3-1000 Series – Labeling, Packaging, and Product Safety 
Basis and Purpose – 3-1005 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(a), 44-10-202(1)(c), 
44-10-202(6), 44-10-203(2)(f), 44-10-203(1)(k), 44-10-203(3)(a)-(b), 44-10-601(2)(a), 44-10-601(5), 44-
10-603(1)(d), 44-10-603(4)(a), and 44-10-603(8), C.R.S. The purpose of this rule is to define minimum 
packaging and labeling requirements for Regulated Marijuana, Regulated Marijuana Concentrate, and 
Regulated Marijuana Product Transferred between Regulated Marijuana Businesses. The State Licensing 
Authority finds it essential to regulate and establish labeling requirements for Regulated Marijuana, 
Regulated Marijuana Concentrate, and Regulated Marijuana Product and that this is in the interest of the 
health and safety of the people of Colorado. This rule identifies information that is required on all labels to 
provide information necessary for the Division to regulate the cultivation, production, and sale of 
Regulated Marijuana, Regulated Marijuana Concentrate, and Regulated Marijuana Product. This rule also 
seeks to minimize, to the extent practicable, the burden of labeling compliance to Licensees. The labeling 
requirements in this rule apply to all Containers immediately containing Regulated Marijuana, Regulated 
Marijuana Concentrate, and Regulated Marijuana Product. This Rule 3-1005 was previously Rules M and 
R 1001-1, 1 CCR 212-1 and 1 CCR 212-2. 
3-1005 - Packaging and Labeling: Minimum Requirements Prior to Transfer to a Regulated 
Marijuana Business, except to a Regulated Marijuana Testing Facility 
A. Applicability. This Rule establishes minimum requirements for packaging and labeling Regulated 
Marijuana prior to Transfer to a Regulated Marijuana Business, except to a Regulated Marijuana 
Testing Facility. See Rule 3-1025 for minimum requirements for packaging and labeling 
Regulated Marijuana prior to Transfer to a Regulated Marijuana Testing Facility. The labeling 
requirements in this Rule apply to all Containers immediately containing Medical Marijuana, 
RetailRegulated Marijuana, Medical Marijuana Concentrate, RetailRegulated Marijuana 
Concentrate, Medical Marijuana Product, and RetailRegulated Marijuana Product. 
B. Packaging and Labeling of Regulated Marijuana Flower, Trim, Wet Whole Plant, and Regulated 
Marijuana Concentrate, Prior to Transfer to a Regulated Marijuana Business. A Regulated 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 201 
Marijuana Business shall comply with the following minimum packaging and labeling 
requirements prior to Transferring Medical Marijuana flower, trim, wet whole plant, or Medical 
Marijuana Concentrate to another Medical Marijuana Business, or Retail Marijuana flower, trim, 
wet whole plant, or Retail Marijuana Concentrate to another Retail Marijuana Business: 
1. Packaging of Regulated Marijuana Flower and Trim, and Regulated Marijuana 
Concentrate. 
a. Prior to Transfer to a Regulated Marijuana Business, Regulated Marijuana 
flower, trim, wet whole plant, or Regulated Marijuana Concentrate shall be placed 
into a Container. The Container may but is not required to be Child-Resistant. 
b. Each Container of Regulated Marijuana flower or trim that is Transferred to a 
Regulated Marijuana Business shall not exceed 50 pounds of Regulated 
Marijuana flower or trim, but may include pre-weighed units that are within the 
sales limit in Rules 5-115(C),6-110(C), and 6-925(G). 
c. A Container of wet whole plant that is Transferred to a Regulated Marijuana 
Business may exceed 50 pounds, but shall not exceed 100 pounds. 
d. Each Container of Medical Marijuana Concentrate that is Transferred to a 
Medical Marijuana Business, or RetailRegulated Marijuana Concentrate that is 
Transferred to a RetailRegulated Marijuana Business, shall not exceed 50 
pounds of Medical Marijuana Concentrate or RetailRegulated Marijuana 
Concentrate, but may include pre-weighed units that are within the applicable 
sales limit in Rules 5-115(C),6-110(C), and 6-925(G). 
2. Labeling of Regulated Marijuana Flower, Trim, Wet Whole Plant, and Regulated 
Marijuana Concentrate. Prior to Transfer to a Regulated Marijuana Business, every 
Container of Regulated Marijuana flower, trim, wet whole plant, or Regulated Marijuana 
Concentrate shall be affixed with a label that includes at least the following information: 
a. The lLicense number of the MedicalRegulated Marijuana Cultivation Facility 
where the MedicalRegulated Marijuana was grown, the Retail Marijuana 
Cultivation Facility where the Retail Marijuana was grown, or the Accelerator 
Cultivator where the Retail Marijuana was grown; 
b. The Harvest Batch Number(s) assigned to the Regulated Marijuana or the 
Production Batch Number(s) assigned to the Regulated Marijuana or the 
Regulated Marijuana Concentrate; 
c. If applicable, the lLicense number of the RegulatedMedical Marijuana Cultivation 
Facility(ies) that produced the Physical Separation-Based MedicalRegulated 
Marijuana Concentrate, the Retail Marijuana Cultivation Facility(ies) that 
produced the Physical Separation-Based Retail Marijuana Concentrate, or the 
license number of the Accelerator Cultivator; 
d. If applicable, the Llicense number of the MedicalRegulated Marijuana Products 
Manufacturer(s) where the MedicalRegulated Marijuana Concentrate was 
produced, the Retail Marijuana Products Manufacturer(s) where the Retail 
Marijuana Concentrate was produced, or the Accelerator Manufacturer(s) where 
the Retail Marijuana Concentrate was produced; 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 202 
e. The net contents, using a standard of measure compatible with the Inventory 
Tracking System, of the Regulated Marijuana or Regulated Marijuana 
Concentrate prior to its placement in the Container; and 
f. Potency test results as required to permit the receiving Regulated Marijuana 
Business to label the Medical Marijuana, RetailRegulated Marijuana, Medical 
Marijuana Concentrate, or RetailRegulated Marijuana Concentrate as required by 
these rules. 
g. Vaporizer Delivery Devices and Pressurized Metered Dose Inhalers. A list of all 
Ingredients, including Additives, used to manufacture the Vaporizer Delivery 
Device or Pressurized Metered Dose Inhaler. 
h. Expiration/Use-By Date. Beginning January 1, 2024, tThe expiration or use-by 
date as required in Rule 3-1015. 
i. Storage Conditions. Beginning January 1, 2024, iIf a Licensee establishes a use-
by date that is longer than nine months based on shelf stability testing in 
accordance with Rule 3-1015(B)(2)(a.5), then the label for the Regulated 
Marijuana shall include storage conditions as determined by the Regulated 
Marijuana Business that cultivated or manufactured the Regulated Marijuana. 
C. Packaging and Labeling of Regulated Marijuana Product Prior to Transfer to a Regulated 
Marijuana Business. A Regulated Marijuana Business shall comply with the following minimum 
packaging and labeling requirements prior to Transferring Medical Marijuana Product to another 
Medical Marijuana Business, or Transferring Retail Marijuana Product to another Retail Marijuana 
Business: 
1. Packaging of Regulated Marijuana Product. 
a. Transfer to a Regulated Marijuana Business Other Than a Medical Marijuana 
Store or RetailRegulated Marijuana Store. Prior to Transfer to a Regulated 
Marijuana Business other than a Medical Marijuana Store or RetailRegulated 
Marijuana Store, Regulated Marijuana Product shall be placed into a Container. 
The Container may but is not required to be Child-Resistant. 
b. Transfer to a Medical Marijuana Store or RetailRegulated Marijuana Store. Prior 
to Transfer to a Medical Marijuana Store or RetailRegulated Marijuana Store, all 
Regulated Marijuana Product shall be packaged in a Child-Resistant Container 
that is ready for sale to the patient or consumer as required by the Rule 3-
1010(D). 
2. Labeling of Regulated Marijuana Product. 
a. Transfer to a Regulated Marijuana Business oOther tThan a Medical Marijuana 
Store or RetailRegulated Marijuana Store. Prior to Transfer to a Regulated 
Marijuana Business other than a Medical Marijuana Store or RetailRegulated 
Marijuana Store, every Container of Regulated Marijuana Product shall be affixed 
with a label that includes at least the following information: 
i. Repealed; 
ii. The license number of the Regulated Marijuana Products Manufacturer 
that produced the Medical Marijuana Product or RetailRegulated 
Marijuana Product; 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 203 
iii. The Production Batch Number(s) assigned to the Regulated Marijuana 
Product; 
iv. The net contents, using a standard of measure compatible with the 
Inventory Tracking System, of the Regulated Marijuana Product prior to 
its placement in the Container; and 
v. Potency test results as required to permit the receiving Regulated 
Marijuana Business to label the Regulated Marijuana Product as 
required by these rules. 
b. Transfer to a Medical Marijuana Store or RetailRegulated Marijuana Store. Prior 
to Transfer to a Regulated Marijuana Store, every Container of Regulated 
Marijuana Product shall be affixed with a label ready for sale to the patient or 
consumer including all information required by Rules 3-1010(D)(2) and 3-
1015(B). 
D. Packaging and Labeling of Genetic Material Prior to Transfer. A Regulated Marijuana Business 
shall comply with the following minimum packaging and labeling requirements prior to 
Transferring Genetic Material: 
1. Repealed. 
2. Packaging of Genetic Material. Prior to Transfer to a Regulated Marijuana Business, 
Genetic Material shall be placed into a receptacle. The receptacle may but is not required 
to be Child-Resistant. 
3. Repealed. 
4. Labeling of Genetic Material. Prior to Transfer to another Regulated Marijuana Business, 
every receptacle of Genetic Material shall be affixed with a label that includes at least the 
license number of the Regulated Marijuana Cultivation Facility Transferring the Genetic 
Material. 
E. Packaging and Labeling of SamplingR-and-D Units. Regulated Marijuana Cultivation Facilities 
and Regulated Marijuana Products Manufacturers shall comply with the following minimum 
packaging and labeling requirements prior to Transferring any SamplingR-and-D Unit to a 
Sampling Managerdesignated employee. 
1. Packaging of SamplingR-and-D Units. Prior to Transfer to a Sampling 
Managerdesignated employee, an SamplingR-and-D Unit must be placed in a Container. 
If the SamplingR-and-D Unit is Regulated Marijuana flower, trim, Medical Marijuana 
Concentrate, or RetailRegulated Marijuana Concentrate, the Container may, but is not 
required to, be Child-Resistant; however, the Container shall be placed into a Child-
Resistant Exit Package at the point of Transfer to the designated employeeSampling 
Manager. If the R-and-DSampling Unit is composed of Regulated Marijuana Product, the 
R-and-DSampling Unit shall be packaged in a Child-Resistant Container. 
2. Labeling of SamplingR-and-D Units. Prior to Transfer to a designated employeeSampling 
Manager, every Container for an SamplingR-and-D Unit shall be affixed with a label that 
includes at least the following information: 
a. Required License Number. The license number for the MedicalRegulated 
Marijuana Cultivation Facility, Retail Marijuana Cultivation Facility, Medical 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 204 
Marijuana Products Manufacturer or RetailRegulated Marijuana Products 
Manufacturer Transferring the SamplingR-and-D Unit. 
b. Batch Number(s). The relevant Harvest Batch number and/or Production Batch 
number from which the SamplingR-and-D Unit was designated. 
c. Universal Symbol. The Universal Symbol on the front of the Container and any 
Marketing Layer, no smaller than ½ of an inch by ½ of an inch, with the following 
statement directly below the Universal Symbol: “Contains Marijuana. Keep 
away from children.” 
d. Required Potency Statement. 
i. For an SamplingR-and-D Unit composed of Regulated Marijuana, 
Medical Marijuana Concentrate, or RetailRegulated Marijuana 
Concentrate, the potency of the SamplingR-and-D Unit’s activeTotal 
THC and CBD expressed as a percentage. 
ii. For an SamplingR-and-D Unit composed of Regulated Marijuana 
Product, the potency of the SamplingR-and-D Unit’s aActive THC and 
CBD expressed in milligrams. If the potency of the SamplingR-and-D 
Unit’s aActive THC or CBD is less than 1 milligram, the potency may be 
expressed as “<1 mg.” 
iii. The required potency statement shall be displayed either: (1) In a font 
that is bold, and enclosed within an outlined shape such as a circle or 
square; or (2) highlighted with a bright color, such as yellow. 
e. Repealed. Date of Transfer. The label shall include the date of Transfer to the 
Sampling Unit. 
f. Repealed.Patient Number. If the Sampling Unit contains Medical Marijuana, 
Medical Marijuana Concentrate, or Medical Marijuana Product, the label must 
also include the patient registration number of the recipient Sampling Manager. 
g. Required Warning Statements. Either the label affixed to the Container or the 
Marketing Layer shall include the following information: 
i. “This product was received as an SamplingR-and-D Unit and may have 
been produced with undisclosed allergens, solvents, or pesticides, and 
may pose unknown physical or mental health risks. This product is not 
for resale and should not be used by anyone else.” 
h. Sale or Resale Prohibited. Either the label affixed to the Container or the 
Marketing Layer shall include a statement indicating the R-and-D Unit must not 
be sold or resold. 
F. Prohibited Transfers – All Regulated Marijuana Businesses. A Regulated Marijuana Business 
shall not Transfer to a MedicalRegulated Marijuana Store, Retail Marijuana Store, Accelerator 
Store, or Retail Marijuana Hospitality and Sales Business—and a MedicalRegulated Marijuana 
Store, Retail Marijuana Store, Accelerator Store, or Retail Marijuana Hospitality and Sales 
Business shall not accept nor offer for sale—any Regulated Marijuana that is not packaged and 
labeled in conformance with the requirements of these rules or that does not provide all 
information necessary to permit the MedicalRegulated Marijuana Store, Retail Marijuana Store, 
Accelerator Store or Retail Marijuana Hospitality and Sales Business to package and label the 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 205 
Regulated Marijuana prior to Transfer to a patient or consumer. However, a MedicalRegulated 
Marijuana Store or Retail Marijuana Store or Retail Marijuana Hospitality and Sales Business is 
not required to open any tamper evident Marketing Layer received from a MedicalRegulated 
Marijuana Cultivation Facility, Retail Marijuana Cultivation Facility, Medical Marijuana Products 
Manufacturer, or a RetailRegulated Marijuana Products Manufacturer to verify the Container is 
Child-Resistant or labeled. 
G. Shipping Containers. Licensees may Transfer multiple Containers of Regulated Marijuana, 
Regulated Marijuana Concentrate, and Regulated Marijuana Product to a Regulated Marijuana 
Business in a Shipping Container. 
1. Inventory Tracking System Tag Required. Licensees shall ensure that either the multiple 
Containers placed within a Shipping Container each have an Inventory Tracking System 
tag, or the Shipping Container itself must have an Inventory Tracking System tag. If the 
Licensee elects to place the Inventory Tracking System tag on the Shipping Container, 
the Shipping Container shall contain only one HarvestProduction Batch of Regulated 
Marijuana, one Production Batch of Regulated Marijuana Concentrate, or one Production 
Batch of Regulated Marijuana Product. If a Shipping Container consists of more than one 
Harvest Batch or Production Batch, then each group of multiple Containers shall be 
affixed with an Inventory Tracking System tag. See Rule 3-805 – Inventory Tracking 
System; Rule 3-605 – Transport: All Regulated Marijuana Businesses. 
2. Labeling of Shipping Containers. Any Shipping Container that will not be displayed to the 
consumer is not required to be labeled according to these rules. 
H. Packaging and Labeling of Regulated Marijuana Flower and Trim Prior to Transfer to a Pesticide 
Manufacturer or a Marijuana Research and Development Facility. The packaging and labeling 
requirements in these 3-1000 Series Rules also apply to any Transfer of Regulated Marijuana, 
Regulated Marijuana Concentrate, or Regulated Marijuana Product to a Pesticide Manufacturer 
or a Marijuana Research and Development Facility. 
I. Marijuana Research and Development Facility Transfers to Persons as Part of an Approved 
Research Project. Any Marijuana Research and Development Facility conducting research as 
part of an approved Research Project involving human subjects shall comply with all packaging 
and labeling requirements that are applicable to a Medical Marijuana Store prior to Transfer to a 
patient, unless the Marijuana Research and Development Facility requests and receives in 
advance a waiver of specific packaging or labeling requirements in connection with the approved 
Research Project. 
J. Research Transfers Prohibited. A MedicalRegulated Marijuana Store, Retail Marijuana Store, or 
Accelerator Store shall not Transfer any MedicalRegulated Marijuana, MedicalRegulated 
Marijuana Concentrate, or MedicalRegulated Marijuana Product, Retail Marijuana, Retail 
Marijuana Concentrate, or Retail Marijuana Product to a Pesticide Manufacturer or a Licensed 
Research Business. 
K. Repealed. 
Basis and Purpose – 3-1010 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(a), 44-10-202(1)(c), 
44-10-202(6), 44-10-203(2)(f), 44-10-203(1)(k), 44-10-203(3)(a)-(b), 44-10-601(2)(a), 44-10-601(5), 44-
10-603(1)(d), 44-10-603(4)(a), and 44-10-603(8), C.R.S. The purpose of this rule is to define general 
packaging and labeling requirements for Regulated Marijuana, Regulated Marijuana Concentrate, and 
Regulated Marijuana Product prior to Transfer to a patient or consumer. The labeling requirements in this 
rule apply to all Containers immediately containing Regulated Marijuana, Regulated Marijuana 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 206 
Concentrate, and Regulated Marijuana Product. The State Licensing Authority finds it essential to 
regulate and establish labeling requirements for Regulated Marijuana, Regulated Marijuana Concentrate, 
and Regulated Marijuana Product and that this is in the interest of the health and safety of the people of 
Colorado. This rule identifies information that is required on all labels to provide necessary information to 
patients and consumers to make informed decisions and first responders in the event of accidental 
ingestion, over ingestion or allergic reaction. This rule also seeks to minimize, to the extent practicable, 
the burden of labeling compliance to Licensees. This Rule 3-1010 was previously Rules M and R 1002-1, 
1 CCR 212-1 and 1 CCR 212-2. 
3-1010 – Packaging and Labeling: General Requirements Prior to Transfer to a Patient or 
Consumer 
A. Applicability. This Rule establishes general requirements for packaging and labeling Regulated 
Marijuana prior to Transfer to a patient or consumer. The labeling requirements in this Rule apply 
to all Containers immediately containing any Regulated Marijuana. The labeling requirements 
based on intended use in Rule 3-1015 are in addition to, not in lieu of, the requirements in this 
Rule. 
1. Exemption for Transfers to Consumers by a Retail Marijuana Hospitality and Sales 
Business. Unless otherwise provided by these rules, a Retail Marijuana Hospitality and 
Sales Business Transferring Retail Marijuana to consumers in compliance with the 
packaging and labeling requirements of Rule 3-1020 is exempt from the requirements of 
this Rule. 
B. Labeling Requirements – All Regulated Marijuana. 
1. Font Size. Required labeling text on the Container and any Marketing Layer must be no 
smaller than 1/16 of an inch. 
2. Labels Shall Not Be Designed to Appeal to Children. A Regulated Marijuana Business 
shall not place any content on a Container or the Marketing Layer in a manner that 
reasonably appears to target individuals under the age of 21, including but not limited to, 
cartoon characters or similar images. 
3. False or Misleading Statements. Label(s) on a Container and any Marketing Layer shall 
not include any false or misleading statements. 
4. Trademark Infringement Prohibited. No Container or Marketing Layer shall be 
intentionally or knowingly labeled so as to cause a reasonable consumer confusion as to 
whether the Regulated Marijuana is a trademarked product or labeled in a manner that 
violates any federal trademark law or regulation. 
5. Health and Benefit Claims. The label(s) on the Container and any Marketing Layer shall 
not make any claims regarding health or physical benefits to the patient or consumer. 
6. Use of English Language. Labeling text on the Container and any Marketing Layer must 
be clearly written or printed and in the English language. In addition to the required 
English label, Licensees may include an additional, accurate foreign language translation 
on the label that otherwise complies with these rules. 
7. Unobstructed and Conspicuous. Labeling text on the Container and any Marketing Layer 
must be unobstructed and conspicuous. A Licensee may affix multiple labels to the 
Container, provided that none of the information required by these rules is obstructed and 
permanently hidden from view. For example and not by means of limitation, labels may 
be accordion, expandable, extendable or layered to permit labeling of small Containers. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 207 
8. Use of the Word “Candy” and/or “Candies” Prohibited. 
a. Licensees shall not use the word(s) “candy” and/or “candies” on the label of any 
Container holding Regulated Marijuana, or of any Marketing Layer. 
b. Notwithstanding the requirements of this subparagraph (B)(8), a Regulated 
Marijuana Business whose iIdentity sStatement contains the word(s) “candy” 
and/or “candies” may place its Identity Statement on the label of the Container 
holding Regulated Marijuana, or of any Marketing Layer. 
9. Child Resistant Certificate(s). A Licensee shall maintain a copy of the certificate showing 
that each Child-Resistant Container into which the Licensee places Regulated Marijuana 
is Child-Resistant and complies with the requirements of 16 C.F.R. 1700.15 (1995) and 
16 C.F.R. 1700.20 (1995) in accordance with the requirements of Rule 3-905(A). 
a. Note that this Rule does not include any later amendments or editions to the 
Code of Federal Regulations. The Division has maintained a copy of 16 C.F.R. 
1700.15 (1995) and 16 C.F.R. 1700.20 (1995), which is available to the public for 
inspection and copying during the Division’s regular business hours. 
10. Containers and Marketing Layers. The Container and any Marketing Layer shall have a 
label with all information required by these 3-1000 Series Rules. Any intermediary 
packaging between the Container and the Marketing Layer is not required to be labeled 
in accordance with these rules. 
11. Exit Packages. 
a. Exit Packages Permitted for Child-Resistant Containers. A MedicalRegulated 
Marijuana Store, Retail Marijuana Store, or Accelerator Store may but is not 
required to place a Child-Resistant Container into an Opaque Exit Package at the 
point of Transfer to the patient or consumer. 
b. Exit Packages Required for Regulated Marijuana Flower and Trim. Any 
Regulated Marijuana flower or trim in a Container that is not Child-Resistant shall 
be placed into a Child-Resistant Exit Package at the point of Transfer to a patient 
or consumer. The Exit Package is not required to be labeled but may include the 
MedicalRegulated Marijuana Store’s, Retail Marijuana Store’s, or Accelerator 
Store’s Identity Statement and/or Standardized Graphic Symbol. 
C. Packaging and Labeling of Regulated Marijuana Flower and Trim, and Regulated Marijuana 
Concentrate Prior to Transfer to a Patient or Consumer. A MedicalRegulated Marijuana Store, 
Retail Marijuana Store, or Accelerator Store shall comply with the following minimum packaging 
and labeling requirements prior to Transferring MedicalRegulated Marijuana flower and trim, 
Retail Marijuana flower and trim, Medical Marijuana Concentrate, or RetailRegulated Marijuana 
Concentrate to a patient or consumer: 
1. Packaging of Regulated Marijuana Flower and Trim. Prior to Transfer to a patient or a 
consumer, Regulated Marijuana flower and trim shall be in a Container that does not 
exceed the sales limit in Rules 5-115(C) orand 6-110(C). The Container may but is not 
required to be Child-Resistant. Any Regulated Marijuana flower and trim in a Container 
that is not Child-Resistant shall be placed into a Child-Resistant Exit Package at the point 
of Transfer to a patient or consumer. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 208 
2. Packaging of Regulated Marijuana Concentrate. Prior to Transfer to a patient or 
consumer, Regulated Marijuana Concentrate shall be in a Child-Resistant Container that 
does not exceed the sales limit in Rules 5-115(C) orand 6-110(C). 
a. A Pressurized Metered Dose Inhaler, Vaporizer Delivery Device, or syringe-type 
device that is within an intended use that is listed in Rule 3-1015(B) and is not an 
Alternative Use Product need not itself be Child-Resistant but must be placed 
into a Child-Resistant Container prior to Transfer to a patient or consumer. 
b. A Pressurized Metered Dose Inhaler, Vaporizer Delivery Device, or syringe-type 
device with an intended use that is listed in Rule 3-1015(B) and that is not an 
Alternative Use Product must be labeled with at least the Universal Symbol, but 
is not required to include “Contains Marijuana. Keep away from children.”, 
prior to Transfer to a patient or consumer. The Universal Symbol shall be legible 
and no smaller than ¼ of an inch by ¼ of an inch. 
c. A Marketing Layer or Container for a Pressurized Metered Dose Inhaler or 
Vaporizer Delivery Device must be affixed with a label that states “Not approved 
by the FDA.” 
d. Nothing in this Rule authorizes the use of a syringe for any type of injection 
involving a needle piercing the skin. 
3. Labeling of Regulated Marijuana Flower and Trim, and Regulated Marijuana 
Concentrate. Prior to Transfer to a patient or consumer, every Container of Regulated 
Marijuana flower and trim, or Regulated Marijuana Concentrate and any Marketing Layer 
shall be affixed with a label that includes at least the following information: 
a. Required License Number(s). The license number for each of the following: 
i. The Regulated Marijuana Cultivation Facility where the Regulated 
Marijuana was grown; 
ii. If applicable, the Regulated Marijuana Cultivation Facility(ies) where the 
Physical Separation-Based MedicalRegulated Marijuana Concentrate or 
Physical Separation-Based Retail Marijuana Concentrate was produced; 
iii. If applicable, the Regulated Marijuana Products Manufacturer where the 
Medical Marijuana Concentrate or RetailRegulated Marijuana 
Concentrate was produced; and 
iv. The Regulated Marijuana Store that sold the Medical Marijuana, 
RetailRegulated Marijuana, Medical Marijuana Concentrate, or 
RetailRegulated Marijuana Concentrate to the patient or consumer, 
except the Regulated Marijuana Store may affix its license number to the 
Container or Marketing Layer. 
v. Retail Marijuana that was designated as Medical Marijuana pursuant to 
Rule 5-235 and, 6-230, 6-730 must be labeled with the license number of 
the Retail Marijuana Cultivation Facility. 
vi. Retail Marijuana Concentrate that was designated as Medical Marijuana 
Concentrate pursuant to Rule 5-335 and, 6-335, 6-830 must be labeled 
with the license number of the Retail Marijuana Products Manufacturer. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 209 
b. Batch Numbers. The Harvest Batch Number(s) assigned to the Regulated 
Marijuana or the Production Batch Number(s) assigned to the Regulated 
Marijuana or the Regulated Marijuana Concentrate. 
c. Statement of Net Contents. The statement of net contents must identify the net 
weight of the Regulated Marijuana or net weight or volume of Regulated 
Marijuana Concentrate prior to its placement in the Container, using a standard 
of measure compatible with the Inventory Tracking System. 
d. Universal Symbol. The Universal Symbol on the front of the Container and any 
Marketing Layer, no smaller than ½ of an inch by ½ of an inch, with the following 
statement directly below the Universal Symbol: “Contains Marijuana. Keep 
away from children.” 
e. Required Potency Statement. 
i. The potency of Regulated Marijuana flower or trim shall be expressed 
as: (1) the percentage of Ttotal THC and CBD from the test results for 
that HarvestProduction Batch, or (2) if the HarvestProduction Batch is 
not required to be tested, either as: (i) a range of percentages of tTotal 
THC and CBD that extends from the lowest percentage to the highest 
percentage for each Cannabinoid listed, from every test conducted on 
that strain of Regulated Marijuana cultivated by the same Regulated 
Marijuana Cultivation Facility during the preceding six months or (ii) an 
average for each Cannabinoid listed, from every test conducted on that 
strain of Regulated Marijuana cultivated by the Regulated Marijuana 
Cultivation Facility during the preceding six months. If CBD is not 
detected in HarvestProduction Batch, then Total CBD potency is not 
required. 
ii. The potency of Medical Marijuana Concentrate’s or Retailthe Regulated 
Marijuana Concentrate’s Total THC and CBD shall be expressed as a 
percentage. If CBD is not detected in the Production Batch, then Total 
CBD potency is not required. The potency of Regulated Marijuana, 
Medical Marijuana Concentrate, and RetailRegulated Marijuana 
Concentrate shall be displayed either: (i) In a font that is bold, and 
enclosed within an outlined shape such as a circle or square; or (ii) 
Highlighted with a bright color such as yellow. 
f. Date of Sale. The Regulated Marijuana Store shall affix the date of sale to the 
patient or consumer to the Container or Marketing Layer. 
g. Patient Number. The Medical Marijuana Store shall affix the patient’s registration 
number to the Container or Marking Layer at the time of Transfer to the patient. 
h. Solvent List. A list of any solvent(s) used to produce any Solvent-Based Medical 
Marijuana Concentrate or Solvent-Based RetailRegulated Marijuana 
Concentrate. 
i. Ingredient List Including Major Allergens. If applicable, a list of all Ingredients 
used to manufacture the Regulated Marijuana Concentrate including 
identification of any major allergens contained in the Regulated Marijuana 
Concentrate in accordance with the Food Allergen Labeling and Consumer 
Protection Act of 2004, 21 U.S.C. § 343 (2010). The Food Allergen Labeling and 
Consumer Protection Act of 2004, 21 U.S.C. § 343 (2010) requires disclosure of 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 210 
the following major food allergens: milk, eggs, fish, crustacean shellfish, tree 
nuts, peanuts, wheat, and soybeans. 
i. Note that this Rule does not include any later amendments or editions to 
the United States Code. The Division maintains a copy of 21 U.S.C. 
§ 343 (2010), which is available to the public for inspection and copying 
during the Division’s regular business hours. 
j. Required Warning Statements. Either the label affixed to the Container or the 
Marketing Layer shall include the following information: 
i. “This product was produced without regulatory oversight for health, 
safety, or efficacy.” 
ii. “There may be long term physical or mental health risks from use of 
marijuana including additional risks for women who are or may 
become pregnant or are breastfeeding. Use of marijuana may impair 
your ability to drive a car or operate machinery.” 
k. Vaporizer Delivery Devices and Pressurized Metered Dose Inhalers. 
i. Ingredient List. A list of all Ingredients, including Additives, used to 
manufacture the Vaporizer Delivery Device or Pressurized Metered Dose 
Inhaler. 
ii. Expiration Date. Effective July 1, 2022, aA Marijuana Products 
Manufacturer that produces a Vaporizer Delivery Device or Pressurized 
Metered Dose Inhaler shall include an expiration date pursuant to Rule 
3-335(M). 
iii. Storage Conditions. Effective July 1, 2022, a A Marijuana Products 
Manufacturer that produces a Vaporizer Delivery Device or Pressurized 
Metered Dose Inhaler shall include ideal storage conditions for the 
Vaporizer Delivery Device or Pressurized Metered Dose Inhaler pursuant 
to Rule 3-335(M). 
D. Packaging and Labeling of Regulated Marijuana Product, Pre-Rolled Marijuana, Infused Pre-
Rolled Marijuana, and Audited Product. A MedicalRegulated Marijuana Products Manufacturer 
and a, Retail Marijuana Products Manufacturer, Accelerator Manufacturer, MedicalRegulated 
Marijuana Store, Retail Marijuana Store, and an Accelerator Store shall comply with the following 
minimum packaging and labeling requirements prior to Transferring Regulated Marijuana 
Product: 
1. Packaging of Regulated Marijuana Product. Every Regulated Marijuana Product shall be 
in a Child-Resistant Container at the time of Transfer to a Medical Marijuana Store or 
RetailRegulated Marijuana Store in accordance with the following packaging limits: 
a. Regulated Marijuana Product Other tThan Edible Medical Marijuana Product or 
Edible RetailRegulated Marijuana Product. MedicalRegulated Marijuana Product 
that is not Edible MedicalRegulated Marijuana Product and Retail Marijuana 
Product that is not Edible Retail Marijuana Product shall be placed into a Child-
Resistant Container that does not exceed the sales limit in Rule 5-115(C) orand 
6-110(C). A Pressurized Metered Dose Inhaler, Vaporizer Delivery Device, or 
syringe-type device that is within the intended use that is listed in Rule 3-1015(B) 
and is not an Alternative Use Product need not itself be Child-Resistant but must 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 211 
be placed into a Child-Resistant Container prior to Transfer to a patient or 
consumer. A Pressurized Metered Dose Inhaler, Vaporizer Delivery Device, or 
syringe-type device within an intended use that is listed in Rule 3-1015(B) and 
that is not an Alternative Use Product must be labeled with at least the Universal 
Symbol, but is not required to include “Contains Marijuana. Keep away from 
children.”, prior to Transfer to a patient or consumer. The Universal Symbol shall 
be legible and no smaller than ¼ of an inch by ¼ of an inch. Nothing in this Rule 
authorizes the use of a syringe for any type of injection involving a needle 
piercing the skin. 
b. Edible Medical Marijuana Product. Every Edible Medical Marijuana Product 
including Liquid Edible Medical Marijuana Product shall be in a Child-Resistant 
Container. If the Edible Medical Marijuana Product contains multiple portions 
then it shall be placed into a Child-Resistant Container that is Resealable. 
c. Edible Retail Marijuana Product. Edible Retail Marijuana Product shall be in a 
Child-Resistant Container as follows: 
i. Single-Serving Edible Retail Marijuana Product. Every Single-Serving 
Edible Retail Marijuana Product must be placed into a Child-Resistant 
Container. 
ii. Bundled Single-Serving Edible Retail Marijuana Product. Single-Serving 
Edible Retail Marijuana Products that are placed into a Child-Resistant 
Container may be bundled into a larger Marketing Layer so long as the 
total amount of aActive THC per Marketing Layer does not exceed 100 
milligrams. 
iii. Multiple-Serving Edible Retail Marijuana Product. Every Multiple-Serving 
Edible Retail Marijuana Product shall be placed into a Child-Resistant 
Container that is Resealable and shall not exceed 100 milligrams of 
aActive THC per Container. 
d. Liquid Edible Medical Marijuana Product and Liquid Edible Retail Marijuana 
Product. Single-serving Liquid Edible Medical Marijuana Product and Ssingle-
Sserving Liquid Edible Retail Marijuana Product shall be packaged in a Child-
Resistant Container: 
i. Repealed. 
ii. Multiple-Serving Liquid Edible Retail Marijuana Product. Each Liquid 
Edible Retail Marijuana Product that is a Multiple-Serving Edible Retail 
Marijuana Product shall be: 
A. Packaged in a structure that uses a single mechanism to achieve 
both Child-Resistant properties and accurate pouring 
measurement of each liquid serving in increments equal to or 
less than 10 milligrams of aActive THC per serving, with no more 
than 100 milligrams of aActive THC total per Container; and 
B. The measurement component is within the Child-Resistant cap 
or closure of the bottle and is not a separate component. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 212 
iii. Multiple-Serving Liquid Edible Medical Marijuana Product. Each Liquid 
Edible Medical Marijuana Product that is a Multiple-Serving Edible 
Medical Marijuana Product shall be: 
A. Packaged in a structure that uses a single mechanism to achieve 
both Child-Resistant properties and accurate pouring 
measurement of each liquid serving; and 
B. The measurement component is within the Child-Resistant cap 
or closure of the bottle, and is not a separate component. 
e. Audited Product. The Container containing Audited Product for administration by: 
(i) metered dose nasal spray or (ii) vaginal administration must be Child 
Resistant and labeled. A Container holding Audited Product for rectal 
administration need not be Child-Resistant but must be placed into a Child-
Resistant Container prior to Transfer to a patient or consumer. 
i. A metered dose nasal spray must be affixed with a label that states: “Not 
approved by FDA.” 
ii. The Container holding Audited Product for vaginal administration and 
rectal administration must be affixed with a label that states: “Not 
approved by FDA.” 
iii. For example and not by means of limitation, labels may be affixed using 
the following methods: accordion, expandable, extendable, layered, tags, 
or stickers. 
2. Labeling of Regulated Marijuana Product. Prior to Transfer to a Regulated Marijuana 
Store and a patient or consumer, every Container of Regulated Marijuana Product and 
any Marketing Layer shall be affixed with a label that includes at least the following 
information: 
a. Required License Number(s). The license number for each of the following: 
i. Repealed. 
ii. The Regulated Marijuana Products Manufacturer where the Medical 
Marijuana Product or RetailRegulated Marijuana Product was produced; 
and 
iii. The Regulated Marijuana Store that sold the MedicalRegulated 
Marijuana Product to a patient or consumer, except the Regulated 
Marijuana Store may affix its license number to the Container or 
Marketing Layer. 
b. Batch Numbers. The Production Batch Number(s) assigned to the Regulated 
Marijuana Product. 
c. Statement of Net Contents. The statement of net contents must identify the net 
weight, volume, or number of Regulated Marijuana Products prior to its 
placement in the Container, using a standard of measure compatible with the 
Inventory Tracking System. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 213 
d. Universal Symbol. The Universal Symbol on the front of the Container and any 
Marketing Layer, no smaller than ½ of an inch by ½ of an inch, with the following 
statement directly below the Universal Symbol: “Contains Marijuana. Keep 
away from children.” 
e. Ingredient List Including Major Allergens. A list of all Ingredients used to 
manufacture the Regulated Marijuana Product including identification of any 
major allergens contained in the Regulated Marijuana Product in accordance with 
the Food Allergen Labeling and Consumer Protection Act of 2004, 21 U.S.C. 
§ 343 (2010). The Food Allergen Labeling and Consumer Protection Act of 2004, 
21 U.S.C. § 343 (2010) requires disclosure of the following major food allergens: 
milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, and soybeans. 
i. Note that this Rule does not include any later amendments or editions to 
the United States Code. The Division maintains a copy of 21 U.S.C. 
§ 343 (2010), which is available to the public for inspection and copying 
during the Division’s regular business hours. 
f. Required Potency Statement. The Target Potency or potency value determined 
from testing by a Regulated Marijuana Testing Facility of the Regulated 
Marijuana Product’s aActive THC and CBD expressed in milligrams. If the 
Regulated Marijuana Product’s Target Potency or potency value of THC or CBD 
is less than 1 milligram, the potency may be expressed as “<1 mg.” If CBD is not 
detected in the Regulated Marijuana Product, then active CBD potency is not 
required. The Target Potency or potency value, shall be displayed either: 
i. In a font that is bold, and enclosed within an outlined shape such as a 
circle or square; or 
ii. Highlighted with a bright color such as yellow. 
g. Solvent List. A list of any solvent(s) used to produce any Solvent-Based Medical 
Marijuana Concentrate used as a production input in any Medical Marijuana 
Product, or Solvent-Based RetailRegulated Marijuana Concentrate used as a 
production input in any RetailRegulated Marijuana Product. 
h. Date of Sale. The Regulated Marijuana Store shall affix the date of sale to the 
Container or Marketing Layer at the time of Transfer to the patient or consumer. 
i. Patient Number. The Medical Marijuana Store shall affix the patient’s registration 
number to the Container or Marking Layer at the time of Transfer to the patient. 
j. Required Warning Statements. Either the label affixed to the Container or the 
Marketing Layer shall include the following information: 
i. “This product was produced without regulatory oversight for health, 
safety, or efficacy.” 
ii. “There may be long term physical or mental health risks from use of 
marijuana including additional risks for women who are or may 
become pregnant or are breastfeeding. Use of marijuana may impair 
your ability to drive a car or operate machinery.” 
3. Labeling of Pre-Rolled Marijuana and Infused Pre-Rolled Marijuana. Prior to Transfer to a 
Regulated Marijuana Store and to a patient or consumer, every Container of Pre-Rolled 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 214 
Marijuana or Infused Pre-Rolled Marijuana and any Marketing Layer shall be affixed with 
a label that includes at least the following information: 
a. Required License Number(s). The license number for each of the following: 
i. The Regulated Marijuana Cultivation Facility where the Medical 
Marijuana or RetailRegulated Marijuana was grown; 
ii. The license number of the Regulated Marijuana Business where the Pre-
Rolled Marijuana or Infused Pre-Rolled Marijuana was produced, if 
different than in subparagraph (D)(3)(a)(i); and 
iii. The Regulated Marijuana Store that sold the Pre-Rolled Marijuana or 
Infused Pre-Rolled Marijuana to a patient or consumer, except the 
Regulated Marijuana Store may affix its license number to the Container 
or Marketing Layer. 
b. Batch Numbers. The Production Batch Number(s) assigned to the Pre-Rolled 
Marijuana or Infused Pre-Rolled Marijuana. 
c. Statement of Net Contents. The statement of net contents must identify the net 
weight (excluding the paper, wrapper, filter and/or equivalent) of each Pre-Rolled 
Marijuana joint or Infused Pre-Rolled Marijuana joint prior to its placement in the 
Container and the number of joints in each Container of Pre-Rolled Marijuana or 
Infused Pre-Rolled Marijuana, using a standard of measure compatible with the 
Inventory Tracking System. 
d. Universal Symbol. The Universal Symbol on the front of the Container and any 
Marketing Layer, no smaller than ½ of an inch by ½ of an inch, with the following 
statement directly below the Universal Symbol: “Contains Marijuana. Keep 
away from children.” 
e. Solvent List. If applicable, a list of any solvent(s) used to produce any Solvent-
Based Medical Marijuana Concentrate or Solvent-Based RetailRegulated 
Marijuana Concentrate used in the creation of Infused Pre-Rolled Marijuana. 
f. Required Potency Statement. The potency of Pre-Rolled Marijuana shall be 
expressed as: (1) the percentage of tTotal THC and CBD from the test results of 
each Production Batch, or (2) if each Production Batch is not required to be 
tested, either as: (i) a range of percentages of total THC and CBD that extends 
from the lowest percentage to the highest percentage for each Cannabinoid 
listed, from every test conducted for a particular type of Pre-Rolled Marijuana 
produced by the same Regulated Marijuana Business during the preceding six 
months or (ii) an average for each Cannabinoid listed, from every test conducted 
for a particular type of Pre-Rolled Marijuana produced by the same Regulated 
Marijuana Business during the preceding six months. If CBD is not detected in 
the Production Batch, then Total CBD potency is not required. The potency of 
Infused Pre-Rolled Marijuana shall be expressed as the percentages of total THC 
and CBD from the test results of each Production Batch. If CBD is not detected in 
the Production Batch, then Total CBD potency is not required. The potency of 
Pre-Rolled Marijuana and Infused Pre-Rolled Marijuana shall be displayed either: 
i. In a font that is bold, and enclosed within an outlined shape such as a 
circle or square; or 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 215 
ii. Highlighted with a bright color such as yellow. 
g. Date of Sale. The Regulated Marijuana Store shall affix the date of sale to the 
Container or Marketing Layer at the time of Transfer to the patient or consumer. 
h. Patient Number. The Medical Marijuana Store shall affix the patient’s registration 
number to the Container or Marking Layer at the time of Transfer to the patient. 
i. Required Warning Statements. Either the label affixed to the Container or the 
Marketing Layer shall include the following information: 
i. “This product was produced without regulatory oversight for 
health, safety, or efficacy.” 
ii. “There may be long term physical or mental health risks from use of 
marijuana including additional risks for women who are or may 
become pregnant or are breastfeeding. Use of marijuana may impair 
your ability to drive a car or operate machinery.” 
4. Packaging of Pre-Rolled Marijuana and Infused Pre-Rolled Marijuana. 
a. Pre-Rolled Marijuana. Prior to Transfer to a patient or a consumer, Pre-Rolled 
Marijuana shall be in a Container that does not exceed the sales limit in Rules 5-
115(C) or 6-110(C). The Container may but is not required to be Child-Resistant. 
Any Pre-Rolled Marijuana in a Container that is not Child-Resistant shall be 
placed into a Child-Resistant Exit Package at the point of Transfer to a patient or 
consumer. 
b. Infused Pre-Rolled Marijuana. Prior to Transfer to a patient or consumer, Infused 
Pre-Rolled Marijuana shall be in a Child-Resistant Container that does not 
exceed the sales limit in Rules 5-115(C) or 6-110(C). 
E. Packaging and Labeling of Seeds and Immature Plants Prior to Transfer to a Patient or 
Consumer. A MedicalRegulated Marijuana Store, Retail Marijuana Store, or Accelerator Store 
shall comply with the following minimum packaging and labeling requirements prior to 
Transferring seeds or Immature plants to a patient or consumer: 
1. Packaging of Regulated Marijuana Seeds. Prior to Transfer to a patient or consumer, 
Regulated Marijuana seeds shall be in a Container. 
2. Packaging of Immature Plants. Prior to Transfer to a patient or consumer, Immature 
Plants shall be placed into a receptacle. 
3. Labeling of Seeds and Immature Plants. Prior to Transfer to a patient or consumer, every 
Container holding Regulated Marijuana seeds and any receptacle containing an 
Immature Plant must be affixed with a label that includes at least the following 
information: 
a. Required License Number(s). The license number for each of the following: 
i. The MedicalRegulated Marijuana Cultivation Facility where the 
MedicalRegulated Marijuana that produced the seeds or Immature Plant 
was grown, the Retail Marijuana Cultivation Facility where the Retail 
Marijuana that produced the seeds or the Immature Plant was grown, or 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 216 
the Accelerator Cultivator where the Retail Marijuana that produced the 
seeds or the Immature Plant was grown; and 
ii. The Medical Marijuana Store that sold the seeds or Immature Plant to 
the patient, or the Retail Marijuana Store that sold the seeds or Immature 
Plant to the consumer, or the Accelerator Store that sold the seeds or 
Immature Plant to the consumer. 
b. Universal Symbol. The Universal Symbol on the front of the Container holding 
seeds and the receptacle containing each Immature Plant, no smaller than ½ of 
an inch by ½ of an inch, with the following statement directly below the Universal 
Symbol: “Contains Marijuana. Keep away from children.” 
c. Statement of Net Contents for Seeds. A statement of net contents identifying the 
number of seeds in the Container. 
d. Date of Sale. The MedicalRegulated Marijuana Store, Retail Marijuana Store, or 
Accelerator Store shall affix the date of sale to the patient or consumer to the 
Container or receptacle. 
e. Patient Number. The Medical Marijuana Store shall affix the patient’s registration 
number to the Container or receptacle at the time of Transfer to the patient. 
f. Required Warning Statements: 
i. “This product was produced without regulatory oversight for health, 
safety, or efficacy.” 
ii. “There may be long term physical or mental health risks from use of 
marijuana including additional risks for women who are or may 
become pregnant or are breastfeeding. Use of marijuana may impair 
your ability to drive a car or operate machinery.” 
F. Permissive Information. 
1. Identity Statement. A label affixed to a Container of Regulated Marijuana, Regulated 
Marijuana Concentrate, and Regulated Marijuana Product or any Marketing Layer may 
include, but is not required to include, the Identity Statement and/or Standardized 
Graphic Symbol for: 
a. The Regulated Marijuana Cultivation Facility(ies) where the Medical Marijuana or 
RetailRegulated Marijuana was grown; 
b. The Regulated Marijuana Products Manufacturer that manufactured the 
Regulated Marijuana Product or Regulated Marijuana Concentrate; and/or 
c. The Regulated Marijuana Store that sold the Regulated Marijuana, Regulated 
Marijuana Concentrate, or Regulated Marijuana Product. 
2. Nutritional Fact Panel. Label(s) may include, but are not required to include, a nutritional 
fact panel or dietary supplement fact panel in substantial conformance with 21 CFR 101.9 
(2016) or 21 C.F.R. 101.36 (2016) as follows: 
a. For Edible Medical Marijuana Products or Edible RetailRegulated Marijuana 
Products other than pills, capsules, and tinctures and Food-Based Regulated 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 217 
Marijuana Concentrate the nutritional fact panel shall be in substantial 
conformance with the requirements of 21 C.F.R. 101.9(C) (2016) which provides 
the FDA’s nutritional labeling requirements for food; 
b. For pills, capsules, and tinctures, the dietary supplement fact panel shall be in 
substantial conformance with the requirements of 21 C.F.R. 101.36 (2016) which 
provides the FDA’s nutritional labeling requirements for dietary supplements. 
i. Note that this Rule does not include any later amendments or editions to 
the Code of Federal Regulations. The Division maintains copies of 21 
C.F.R. 101.9(C) (2016) and 21 C.F.R. 101.36 (2016), which are available 
to the public for inspection and copying during the Division’s regular 
business hours. 
3. Other Permissive Information. The labeling requirements in the 3-1000 Series Rules 
provide only the minimum labeling requirements. Licensees may include additional 
information on the label(s) so long as such information is consistent with the 
requirements of these Rules. 
Basis and Purpose – 3-1015 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(a), 44-10-202(1)(c), 
44-10-202(6), 44-10-203(2)(d)(IV)(A)-(C), 44-10-203(2)(f), 44-10-203(2)(w), 44-10-203(1)(a), 44-10-
601(2)(a), 44-10-603(4)(a), and 44-10-603(8), C.R.S. The purpose of this rule is to define additional 
labeling requirements for Regulated Marijuana, Regulated Marijuana Concentrate, and/or Regulated 
Marijuana Product (except Regulated Marijuana Genetic Material) based on its intended use. These 
labeling requirements are in addition to, not in lieu of, the labeling requirements in Rule 3-1010. This Rule 
3-1015 was previously Rules M and R 1003-1, 1 CCR 212-1 and 1 CCR 212-2. The Division and State 
Licensing Authority intend to monitor data regarding Regulated Marijuana use-by dates following 
implementation of these rules, and will make any necessary changes, including but not limited to, 
reducing the nine months use-by date if Licensees choose not to conduct stabilization studies. 
3-1015 – Additional Labeling Requirements Prior to Transfer to a Patient or Consumer 
A. Applicability. This Rule establishes additional labeling requirements for Regulated Marijuana 
(except Genetic Material), Regulated Marijuana Concentrate, and Regulated Marijuana Product 
prior to Transfer to a patient or consumer. The labeling requirements in this Rule apply to all 
Containers immediately containing Regulated Marijuana, Regulated Marijuana Concentrate, and 
Regulated Marijuana Product. These labeling requirements based on intended use are in addition 
to, not in lieu of, the requirements in Rule 3-1010. 
1. Exemption for Transfers to Consumers by a Retail Marijuana Hospitality and Sales 
Business. Unless otherwise provided by these rules, a Retail Marijuana Hospitality and 
Sales Business Transferring Retail Marijuana to consumers in compliance with the 
packaging and labeling requirements of Rule 3-1020 is exempt from the requirements of 
this Rule. 
B. Additional Information Required on Every Container (Except Genetic Material) Prior to Transfer to 
a Patient or Consumer. Prior to Transfer to a patient or consumer, every Container of Regulated 
Marijuana (except Genetic Material), Regulated Marijuana Concentrate, or Regulated Marijuana 
Product and any Marketing Layer must have a label that includes at least the following additional 
information. 
1. Statement of Intended Use. The Container and any Marketing Layer shall identify one or 
more intended use(s) for Medical Marijuana, RetailRegulated Marijuana, Medical 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 218 
Marijuana Concentrate, RetailRegulated Marijuana Concentrate, Medical Marijuana 
Product, and RetailRegulated Marijuana Product from the following exclusive list: 
a. Inhaled Product: 
i. Flower, shake, or trim; 
ii. Pre-Rolled Marijuana and Infused-Pre-Rolled Marijuana; 
iii. Solvent-Based Medical Marijuana Concentrate; 
iv. Solvent-Based Retail Marijuana Concentrate; 
v. Physical Separation-Based Medical Marijuana Concentrate; 
vi. Physical Separation-Based Retail Marijuana Concentrate; 
vii. Heat/Pressure-Based Medical Marijuana Concentrate; 
viii. Heat/Pressure-Based Retail Marijuana Concentrate; 
ix. Vaporizer Delivery Device; 
x. Pressurized Metered Dose Inhaler. 
b. For Oral Consumption: 
i. Food or drink infused with Regulated Marijuana; 
ii. Regulated Marijuana Concentrate intended to be consumed orally; 
iii. Pills and capsules; 
iv. Tinctures. 
c. Skin and Body Products: 
i. Topical; 
ii. Transdermal. 
d. Audited Product: 
i. Metered Dose Nasal Spray; 
ii. Vaginal Administration; 
iii. Rectal Administration. 
2. Inhaled Product. The “Iinhaled Pproduct” intended use may be used only for products 
intended for consumption by smoking or Vaporizer Delivery Device where the product is 
heated or burned prior to consumption, or through use of a Pressurized Metered Dose 
Inhaler. The label(s) on all inhaled product intended use shall also include: 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 219 
a. The potency statement required by Rule 3-1010 for: (1) flower, shake, or trim, (2) 
Pre-Rolled Marijuana, (3) Infused-Pre-Rolled Marijuana, (4) Solvent-Based 
Medical Marijuana Concentrate, (5) Solvent-Based Retail Marijuana Concentrate, 
(6) Physical Separation-Based Medical Marijuana Concentrate, (7) Physical 
Separation-Based Retail Marijuana Concentrate, (8) Heat/Pressure-Based 
Medical Marijuana Concentrate, (9) Heat/Pressure-Based Retail Marijuana 
Concentrate shall be stated as the percentage of Total THC and CBD. If CBD is 
not detected, then total CBD potency is not required. 
a.5. Use-By Date for Inhaled Products Other Than Vaporizer Delivery Devices and 
Pressurized Metered Dose Inhalers. Effective January 1, 2024, aA product use-
by date, upon which the Regulated Marijuana, Regulated Marijuana Concentrate, 
or Regulated Marijuana Product will no longer be fit for consumption, or upon 
which the Regulated Marijuana, Regulated Marijuana Concentrate, or Regulated 
Marijuana Product will no longer be optimally fresh. Once a label with a use-by 
date has been affixed to a Container containing Regulated Marijuana, Regulated 
Marijuana Concentrate, or Regulated Marijuana Product and any Marketing 
Layer, a Licensee shall not alter that use-by date or affix a new label with a later 
use-by date. The use-by date shall not be longer than nine months from the 
harvest or production date, unless shelf stability testing, including but not limited 
to potency, microbial, and water activity testing, supports a longer shelf life. All 
use-by dates must be entered into the Inventory Tracking System prior to 
Transfer. Prior to Transfer to a patient or consumer, a Regulated Marijuana Store 
or Accelerator Store must inform the patient or consumer if the Regulated 
Marijuana, Regulated Marijuana Concentrate, or Regulated Marijuana Product is 
past its use-by date. 
a.6. Expiration Date for Vaporizer Delivery Devices and Pressurized Metered Dose 
Inhalers. Licensees must identify an expiration date upon which the Vaporizer 
Delivery Device or Pressurized Metered Dose Inhaler will no longer be fit for 
consumption in accordance with Rule 3-335(M). Once a label with an expiration 
date has been affixed to a Container containing a Vaporizer Delivery Device or 
Pressurized Metered Dose Inhaler and any Marketing Layer, a Licensee shall not 
alter that expiration date or affix a new label with a later expiration date. All 
expiration dates must be entered into the Inventory Tracking System prior to 
Transfer. 
b. The potency statement required by Rule 3-1010 for Vaporizer Delivery Devices 
and Pressurized Metered Dose Inhalers shall be stated as either the percentage 
of Total THC and CBD, or the number of milligrams of Total THC and CBD, per 
cartridge, pen, or inhaler. If the potency value for Total THC or CBD of the 
Vaporizer Delivery Devices or Pressurized Metered Dose Inhalers is less than 
one milligram, the potency may be expressed as “<1 mg.” If CBD is not detected 
in the Vaporizer Delivery Device or Pressurized Metered Dose Inhaler, then total 
CBD potency is not required. 
c. Additional Labeling Requirement for Regulated Marijuana Concentrate to 
Promote Consumer Health and Awareness: Effective January 1, 2023, iIf a 
Regulated Marijuana Concentrate that is an Inhaled Product cannot easily be 
measured or separable to the recommended serving size established under Rule 
3-335(D)(3)(d) and (4)(f), the Regulated Marijuana Products Manufacturer that 
manufacturers the Regulated Marijuana Concentrate must: 
i. Affix the Container of Regulated Marijuana Concentrate with a 
measuring device that permits the patient or consumer to measure each 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 220 
serving in a manner consistent with the recommended serving 
established under Rule 3-335(D); or 
ii. Include a label on the Container of Regulated Marijuana Concentrate 
that provides instructions to allow the patient or consumer to measure 
each recommended serving pursuant to Rule 3-335(D). 
3. For Oral Consumption. The label(s) on all Edible Medical Marijuana Products and Edible 
RetailRegulated Marijuana Products, including but not limited to confections, liquids, pills, 
capsules and tinctures, shall also include: 
a. Potency Statement. The potency statement required by Rule 3-1010 shall be 
stated as: (1) milligrams of aActive THC and CBD per serving and (2) milligrams 
of aActive THC and CBD per Container where the Container contains more than 
one serving. The Target Potency may be used to fulfill the requirement of this 
Rule. If CBD is not detected, then active CBD potency is not required. 
i. If the Edible Medical Marijuana Product’s or Edible RetailRegulated 
Marijuana Product’s Target Potency or potency value of aActive THC or 
CBD is less than one milligram per serving, the potency may be 
expressed as “<1 mg.” If “<1 mg” was used to display the aActive THC or 
CBD per serving, then a corresponding statement regarding the total 
Active THC or CBD content for the entire Container shall be included on 
the Container. For example, if there are five servings in the Container, 
“<5 mg” should be displayed for the aActive THC or CBD statement that 
was represented as “<1 mg” per serving. 
b. Additional Warning Statement Required. The following additional warning 
statement shall be included on the label on the Container or Marketing Layer for 
all Edible Medical Marijuana Product and Edible RetailRegulated Marijuana 
Product: “The intoxicating effects of this product may be delayed by up to 4 
hours.” 
c. Expiration/Use-By Date. A product expiration date, upon which the Edible 
Regulated Marijuana Product will no longer be fit for consumption, or a use-by-
date, upon which the Edible Medical Marijuana Product or Edible 
RetailRegulated Marijuana Product will no longer be optimally fresh. Once a label 
with an expiration or use-by date has been affixed to a Container containing an 
Edible Regulated Marijuana Product and any Marketing Layer, a Licensee shall 
not alter that expiration or use-by date or affix a new label with a later expiration 
or use-by date. All expiration or use-by dates must be entered into the Inventory 
Tracking System prior to Transfer. 
i. Prior to Transfer to a patient or consumer, a Regulated Marijuana Store 
or Accelerator Store must inform the patient or consumer if the Edible 
Regulated Marijuana Product is past its use-by date. 
ii. If an Edible Regulated Marijuana Product is labeled with an expiration 
date, a Regulated Marijuana Store shall not Transfer the product to a 
patient or consumer past the labeled expiration date. 
d. Production Date. The date on which the Edible Regulated Marijuana Product was 
produced which may be included in the Batch Number required by Rule 3-1010. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 221 
e. Statement Regarding Refrigeration. If an Edible Regulated Marijuana Product is 
perishable, a statement that the product must be refrigerated. 
4. Skin and Body Products (Topical and Transdermal). The “Skin and Body Products” 
intended use may be used only for products intended for consumption by topical or 
transdermal application, and must be intended for external use only. The label(s) on all 
skin and body products shall also include: 
a. Topical Product Potency Statement. For topical product the potency statement 
required by Rule 3-1010 shall be stated as the number of milligrams of aActive 
THC and CBD per Container. The Target Potency may be used to fulfill the 
requirement of this Rule. If CBD is not detected, then active CBD potency is not 
required. If the THC or CBD comprises less than one percent of the total 
Cannabinoids, the potency may be expressed as less than one percent of the 
total Cannabinoids. 
b. Transdermal Product Potency Statement. For transdermal product, the potency 
statement required by Rule 3-1010 shall be stated as the number of milligrams of 
aActive THC and CBD per transdermal product, and the total number of 
milligrams of aActive THC and CBD per Container. The Target Potency may be 
used to fulfill the requirement of this Rule. If CBD is not detected, then active 
CBD potency is not required. 
i. If the transdermal product’s Target Potency or potency value of aActive 
THC or CBD is less than one milligram per transdermal product, the 
potency may be expressed as “<1 mg.” If “<1 mg” was used to display 
the aActive THC or CBD per transdermal product, then a corresponding 
statement regarding the total Active THC or CBD content for the entire 
Container shall be included on the Container. For example, if there are 
five servings in the Container, “<5 mg” should be displayed for the 
aActive THC or CBD statement that was represented as “<1 mg” per 
serving. 
c. Use-By Date. A product use-by date, after which the skin and body product will 
no longer be fit for use. Once a label with a use-by date has been affixed to any 
Container holding a skin and body product and any Marketing Layer, a Licensee 
shall not alter that use-by date or affix a new label with a later use-by date. All 
use-by dates must be entered into the Inventory Tracking System prior to 
Transfer. Prior to Transfer to a patient or consumer, a Regulated Marijuana Store 
or Accelerator Store must inform the patient or consumer if the skin and body 
product is past its use-by date. 
d. Repealed. 
5. Audited Product. Packaging and labeling for all Audited Products: (i) metered dose nasal 
spray, (ii) vaginal administration, or (iii) rectal administration shall include: 
a. All packaging and labeling requirements required by this 3-1000 Series for 
Regulated Marijuana Products; except Rules 5-325 and 6-325 control where the 
context otherwise clearly requires. 
b. Audited Product shall be packaged and labeled for Transfer to a patient or 
consumer prior to Transfer from a Medical Marijuana Products Manufacturer or 
RetailRegulated Marijuana Products Manufacturer. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 222 
c. Expiration Date. A product expiration date that is appropriate for the Audited 
Product when stored at room temperature as verified by testing required by 
Rules 5-325 and 6-325. Once a label with an expiration date has been affixed to 
a Container containing an Audited Product, a Licensee shall not alter that 
expiration date or affix a new label with a later expiration date. All expiration 
dates must be entered into the Inventory Tracking System prior to Transfer. 
d. Repealed. 
C. No Other Intended Use Permitted. No intended use other than those identified in this Rule shall 
be identified on any label, except as permitted by an Alternative Use Designation approved by the 
State Licensing Authority pursuant to Rules 5-325 and 6-325. Licensees shall accurately identify 
all intended use(s) from the exclusive list of intended uses in this Rule, or as required by the 
Alternative Use Designation, on the label. 
1. Alternative Use Product. No Regulated Marijuana Business shall Transfer or accept an 
Alternative Use Product unless the Alternative Use Product received an Alternative Use 
Designation in accordance with Rules 5-325 and 6-325 and complied with all the 
requirements of Rules 5-325, 6-325, and 3-1005 through 3-1015, and with any additional 
packaging and labeling requirements identified in the Alternative Use Designation. At a 
minimum the label(s) on all Alternative Use Products shall include: 
a. All packaging and labeling requirements applicable to the Medical Marijuana 
Products Manufacturer or RetailRegulated Marijuana Products Manufacturer by 
these 3-1000 Series Rules unless inconsistent with the Alternative Use 
Designation in which case the Alternative Use Designation shall control. 
b. Expiration Date. A product expiration date that is appropriate for the Alternative 
Use Product when stored at room temperature as verified by a Regulated 
Marijuana Testing Facility. Once a label with an expiration date has been affixed 
to a Container containing Alternative Use Product, a Licensee shall not alter that 
expiration date or affix a new label with a later expiration date. 
c. Repealed. 
d. All other requirements identified by the Alternative Use Designation. 
D. Multiple Intended Uses. Any Regulated Marijuana having more than one intended use shall 
identify every intended use on the label and shall comply with all labeling requirements for each 
intended use. If there is any conflict between the labeling requirements for multiple intended uses, 
the most restrictive labeling requirements shall be followed. Licensees shall not counsel or advise 
any patient or consumer to use Regulated Marijuana other than in accordance with the intended 
use(s) identified on the label. 
E. Repealed. 
Basis and Purpose – 3-1020 
The statutory authority for this rule includes but is not limited to 44-10-202(1)(a), 44-10-202(1)(c), 44-10-
202(6), 44-10-203(2)(ff), 44-10-305(2)(b), 44-10-609, and 44-10-610, C.R.S. The purpose of this rule is to 
define minimum packaging and labeling requirements for Retail Marijuana Hospitality and Sales 
Businesses. 
3-1020 – Packaging and Labeling: Requirements for Transfers to a Consumer at a Retail Marijuana 
Hospitality and Sales Business 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 223 
A. Applicability. This Rule establishes minimum requirements for packaging and labeling Retail 
Marijuana Transferred to a consumer at a Retail Marijuana Hospitality and Sales Business. 
B. Packaging and Labeling Exemptions and Minimum Requirements. A Retail Marijuana Hospitality 
and Sales Business may Transfer Retail Marijuana to a consumer without packaging and labeling 
under the following conditions: 
1. The consumer intends to consume the Retail Marijuana on the Licensed Premises of the 
Retail Marijuana Hospitality and Sales Business; 
2. At the time of Transfer to a consumer, the Retail Marijuana Hospitality and Sales 
Business provides the consumer with a written statement of the potency of the Retail 
Marijuana’s and Retail Marijuana Concentrate’s activeTotal THC and CBD, which shall 
be expressed as a percentage for Retail Marijuana and Retail Marijuana Concentrate, 
and a written statement of the potency of the Retail Marijuana Product’s Active THC and 
CBD, which shall be expressed in milligrams for Retail Marijuana Product. If CBD is not 
detected in the Retail Marijuana, then active CBD potency is not required; 
3. The Retail Marijuana Hospitality and Sales Business maintains within the Restricted 
Access Area of the Licensed Premises—and makes available to the consumer upon 
request—written or electronic documentation reflecting all relevant information required in 
Rules 3-1010 and 3-1015; and 
4. For Multiple-Serving Edible Retail Marijuana Product or Multiple-Serving Liquid Edible 
Retail Marijuana Product, the Retail Marijuana Hospitality and Sales Business shall at the 
time of Transfer to the consumer provide a measurement device necessary for the 
consumer to achieve accurate measurements of each serving in increments equal to or 
less than 10 milligrams of aActive THC per serving. 
C. Packaging and Labeling Required Before Retail Marijuana is Removed from the Licensed 
Premises. Prior to a consumer removing any unconsumed Retail Marijuana from the Licensed 
Premises, the Retail Marijuana Hospitality and Sales Business shall: 
1. Provide the consumer with written or electronic documentation reflecting all relevant 
information required in Rules 3-1010 and 3-1015; and 
2. Place the unconsumed Retail Marijuana into a Child-Resistant Container, or if the 
Container is not Child-Resistant, a Child-Resistant Exit Package. The Container must be 
affixed with a label that includes at least the following: 
a. Universal Symbol. The Universal Symbol on the Container, no smaller than ½ 
inch by ½ inch, with the following statement directly below the Universal Symbol: 
“Contains Marijuana. Keep away from children.”; and 
b. Required Potency Statement. A written statement of the potency of the Retail 
Marijuana’s tTotal THC and CBD expressed as a percentage. A written 
statement of the potency of the Retail Marijuana Product’s aActive THC and CBD 
expressed in milligrams. If the potency of the Regulated Marijuana Product’s 
aActive THC or CBD is less than 1 milligram, the potency may be expressed as 
“<1 mg.” If CBD is not detected in the Retail Marijuana, then active CBD potency 
is not required. 
c. For Multiple-Serving Edible Retail Marijuana Product or Multiple-Serving Liquid 
Edible Retail Marijuana Product, the Retail Marijuana Hospitality and Sales 
Business shall provide a measurement device necessary for the consumer to 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 224 
achieve accurate measurements of each serving in increments equal to or less 
than 10 milligrams of aActive THC per serving. 
D. Additional Packaging and Labeling Requirements for Retail Marijuana Hospitality and Sales 
Businesses. 
1. Font Size. Required labeling text on the Container must be no smaller than 1/16 of an 
inch. 
2. Labels Shall Not Be Designed to Appeal to Children. A Retail Marijuana Hospitality and 
Sales Business shall not place any content on a Container that reasonably appears to 
target individuals under the age of 21, including but not limited to, cartoon characters or 
similar images. 
3. False or Misleading Statements. Label(s) on a Container shall not include any false or 
misleading statements. 
4. Trademark Infringement Prohibited. No Container shall be intentionally or knowingly 
labeled so as to cause a reasonable consumer confusion as to whether the Retail 
Marijuana is a trademarked product or labeled in a manner that violates any federal 
trademark law or regulation. 
5. Health and Benefit Claims. The label(s) on the Container shall not make any claims 
regarding health or physical benefits to the consumer. 
6. Use of English Language. Labeling text on the Container must be clearly written or 
printed and in the English language. In addition to the required English label, Licensees 
may include an additional, accurate foreign language translation on the label that 
otherwise complies with these rules. 
7. Unobstructed and Conspicuous. Labeling text on the Container must be unobstructed 
and conspicuous. A Licensee may affix multiple labels to the Container, provided that 
none of the information required by these rules is obstructed. For example and not by 
means of limitation, labels may be accordion, expandable, extendable or layered to 
permit labeling of small Containers. 
8. Use of the Word “Candy” and/or “Candies” Prohibited. Licensees shall not use the 
word(s) “candy” and/or “candies” on the label of any Container. 
9. Child Resistant Certificate(s). A Licensee shall maintain a copy of the certificate showing 
that each Child-Resistant Container into which the Licensee places Retail Marijuana is 
Child-Resistant and complies with the requirements of 16 C.F.R. 1700.15 (1995) and 16 
C.F.R. 1700.20 (1995) in accordance with the requirements of Rule 3-905(A). Note that 
this Rule does not include any later amendments or editions to the Code of Federal 
Regulations. The Division has maintained a copy of 16 C.F.R. 1700.15 (1995) and 16 
C.F.R. 1700.20 (1995), which is available to the public for inspection and copying during 
the Division’s regular business hours. 
Basis and Purpose – 3-1025 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(a), 44-10-202(1)(c), 
44-10-202(6), 44-10-203(2)(f), 44-10-203(1)(k), 44-10-203(3)(a)-(b), C.R.S. The purpose of this rule is to 
define minimum packaging and labeling requirements for Regulated Marijuana, Regulated Marijuana 
Concentrate, and Regulated Marijuana Product Transferred to a Regulated Marijuana Testing Facility. 
The labeling requirements in this rule apply to all Containers immediately containing Regulated 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 225 
Marijuana, Regulated Marijuana Concentrate, and Regulated Marijuana Product being Transferred to a 
Regulated Marijuana Testing Facility. 
3-1025 – Packaging and Labeling: Minimum Requirements for Test Batch Transfers to a Regulated 
Marijuana Testing Facility 
A. Applicability. This Rule establishes minimum requirements for packaging and labeling of 
Regulated Marijuana Test Batches prior to Transfer to a Regulated Marijuana Testing Facility. 
The labeling requirements in this Rule apply to all Containers immediately containing 
MedicalRegulated Marijuana, Retail Marijuana, MedicalRegulated Marijuana Concentrate, Retail 
Marijuana Concentrate, Medicaland Regulated Marijuana Product, and Retail Marijuana Product. 
B. Packaging and Labeling of Test Batches of Regulated Marijuana Flower, Trim, Wet Whole Plant, 
and Regulated Marijuana Concentrate, Prior to Transfer to a Regulated Marijuana Testing 
Facility. A Regulated Marijuana Business shall comply with the following minimum packaging and 
labeling requirements prior to Transferring Test Batches of MedicalRegulated Marijuana flower, 
trim, wet whole plant, or MedicalRegulated Marijuana Concentrate to a MedicalRegulated 
Marijuana Testing Facility, and prior to Transferring Test Batches of Retail Marijuana flower, trim, 
wet whole plant, or Retail Marijuana Concentrate to a Retail Marijuana Testing Facility: 
1. Packaging of Test Batches of Regulated Marijuana Flower, Trim, Wet Whole Plant and 
Regulated Marijuana Concentrate. 
a. A Licensee shall submit Test Batches of Regulated Marijuana flower, trim, wet 
whole plant, or Regulated Marijuana Concentrate in a transparent Container to 
allow for the Sample Increments of the Test Batch to be photo documented. 
b. Each Container containing a Test Batch of Regulated Marijuana flower, trim, or 
wet whole plant shall have at least 20% empty space. Test Batch Containers 
shall not be completely full so that individual Sample Increments of the Test 
Batch can be photo documented. 
c. Vaporizer Delivery Devices and Pressurized Metered Dose Inhalers. Test 
Batches from Production Batches of Vaporizer Delivery Devices and Pressurized 
Metered Dose Inhalers must be packaged in the hardware or inhaler, 
respectively, that allows for the consumption. 
2. Labeling of Test Batches of Regulated Marijuana Flower, Trim, Wet Whole Plant and 
Regulated Marijuana Concentrate. Prior to Transfer to a Regulated Marijuana Testing 
Facility, every Container containing a Test Batch of Regulated Marijuana flower, trim, wet 
whole plant, or Regulated Marijuana Concentrate shall be affixed with a label that 
includes at least the following information, some of which may be included on the 
Inventory Tracking System Tag: 
a. For Test Batches of Regulated Marijuana from HarvestProduction Batches, the 
license number of the Medical Marijuana Cultivation Facility where the Medical 
Marijuana was grown, or the RetailRegulated Marijuana Cultivation Facility where 
the RetailRegulated Marijuana was grown; 
b. For Test Batches of Regulated Marijuana Concentrates from Production Batches, 
the license number of the Medical Marijuana Products Manufacturer(s) where the 
Medical Concentrate was produced, or the RetailRegulated Marijuana Products 
Manufacturer(s) where the RetailRegulated Marijuana Concentrate was 
produced; and 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 226 
c. The net contents, using a standard of measure compatible with the Inventory 
Tracking System, of the Regulated Marijuana or Regulated Marijuana 
Concentrate prior to its placement in the Container. 
C. Packaging and Labeling of Test Batches of Regulated Marijuana Product Prior to Transfer to a 
Regulated Marijuana Testing Facility. A Regulated Marijuana Business shall comply with the 
following minimum packaging and labeling requirements prior to Transferring Test Batches of 
Regulated Marijuana Product to a Regulated Marijuana Testing Facility: 
1. Packaging Test Batches of Regulated Marijuana Product. 
a. Prior to any Transfer of a Test Batch to a Regulated Marijuana Testing Facility, 
the Test Batch of Regulated Marijuana Product subject to testing shall be placed 
into the Container(s) in which the rest of the Production Batch will be sold. The 
Container may but is not required to be Child-Resistant. 
2. Labeling of Test Batches of Regulated Marijuana Product. Prior to Transfer to a 
Regulated Marijuana Testing Facility, every Container containing a Test Batch of 
Regulated Marijuana Product shall be affixed with a label, which can be noted on the 
Inventory Tracking System Inventory Tracking System Tag, that includes at least the 
following information: 
a. The license number of the Medical Marijuana Products Manufacturer or the 
RetailRegulated Marijuana Products Manufacturer that produced the Regulated 
Marijuana Product; 
b. The Production Batch Number(s) assigned to the Regulated Marijuana Product; 
c. The net contents, using a standard of measure compatible with the Inventory 
Tracking System, of the Regulated Marijuana Product prior to its placement in 
the Container; and 
d. The serving size, number of serving per package, and the Target Potency as 
required for a Regulated Marijuana Testing Facility to assess potency variance 
for, at a minimum, but not limited to, Active THC. 
D. Packaging and Labeling of Test Batches of Pre-Rolled Marijuana and Infused Pre-Rolled 
Marijuana, Prior to Transfer to a Regulated Marijuana Testing Facility. A Regulated Marijuana 
Business shall comply with the following minimum packaging and labeling requirements prior to 
Transferring Test Batches of Pre-Rolled Marijuana and Infused Pre-Rolled Marijuana to a Medical 
Marijuana Testing Facility, and prior to Transferring Test Batches of Pre-Rolled Marijuana and 
Infused Pre-Rolled Marijuana to a RetailRegulated Marijuana Testing Facility: 
1. Packaging of Test Batches of Pre-Rolled Marijuana and Infused Pre-Rolled Marijuana. 
a. Prior to any Transfer of a Test Batch to a Regulated Marijuana Testing Facility, 
the Test Batch of Pre-Rolled Marijuana and Infused Pre-Rolled Marijuana subject 
to testing shall be placed into the Container(s) in which the rest of the Production 
Batch will be sold. The Container may but is not required to be Child-Resistant. 
2. Labeling of Test Batches of Pre-Rolled Marijuana and Infused Pre-Rolled Marijuana. 
Prior to Transfer to a Regulated Marijuana Testing Facility, every Container containing a 
Test Batch of Pre-Rolled Marijuana and Infused Pre-Rolled Marijuana shall be affixed 
with a label that includes at least the following information, some of which may be 
included on the Inventory Tracking System Inventory Tracking System Tag: 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 227 
a. For Test Batches of Regulated Marijuana flower or trim from HarvestProduction 
Batches, the lLicense number of the Medical Marijuana Cultivation Facility where 
the Medical Marijuana was grown, or the RetailRegulated Marijuana Cultivation 
Facility where the RetailRegulated Marijuana was grown which was used to 
create Pre-Rolled Marijuana and Infused Pre-Rolled Marijuana; 
b. For Test Batches of Regulated Marijuana Concentrates from Production Batches, 
the Llicense number of the Medical Marijuana Products Manufacturer(s) where 
the Medical Concentrate was produced, or the RetailRegulated Marijuana 
Products Manufacturer(s) where the RetailRegulated Marijuana Concentrate was 
produced which was used to create Pre-Rolled Marijuana and Infused Pre-Rolled 
Marijuana; 
c. The Production Batch Number(s) assigned to the Pre-Rolled Marijuana and 
Infused Pre-Rolled Marijuana; and 
d. The net contents, using a standard of measure compatible with the Inventory 
Tracking System, of the Regulated Marijuana or Regulated Marijuana 
Concentrate prior to its placement in the Container. 
3-1100 Series – Accelerator Program Operations 
Basis and Purpose – 3-1105 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-
203(2)(aa), 44-10-310(2), and 44-10-311(2), C.R.S. The purpose of this rule is to establish requirements 
for Accelerator-Endorsed Licensees and Accelerator Licensees participating in the accelerator program. 
The Accelerator Program permits different structures. The first option is for the Accelerator-Endorsed 
Licensee and the Accelerator Licensee to have a mentor/apprentice relationship at the same premises 
pursuant to Rules 3-1105 and 3-1110. The second option is for the Accelerator-Endorsed Licensee and 
the Accelerator Licensee to have a separate premises relationship pursuant to Rules 3-1105 and 3-1115. 
3-1105 – Accelerator Program Participation and Privileges 
A. Licensed Premises. An Accelerator Licensee may share a Licensed Premises or operate at a 
separate premises of a Retail Marijuana Cultivation Facility, Retail Marijuana Products 
Manufacturer, or Retail Marijuana Store that is an Accelerator-Endorsed Licensee. 
1. Shared Premises. An Accelerator Licensee may share the Licensed Premises of a Retail 
Marijuana Cultivation Facility, Retail Marijuana Products Manufacturer, or Retail 
Marijuana Store pursuant to this Rule 3-1105 and Rule 3-1110. The Accelerator Licensee 
may share the Licensed Premises with a Retail Marijuana Cultivation Facility, Retail 
Marijuana Products Manufacturer, or Retail Marijuana Store that is the Accelerator-
Endorsed Licensee and is co-located with a Medical Marijuana Cultivation Facility, 
Medical Marijuana Products Manufacturer, or Medical Marijuana Store, respectively. 
2. Separate Premises. An Accelerator Licensee participating in the accelerator program 
may operate at a separate premises of a Retail Marijuana Cultivation Facility, Retail 
Marijuana Products Manufacturer, or Retail Marijuana Store pursuant to this Rule 3-1105 
and Rule 3-1115. 
B. Number of Licenses held by an Accelerator Licensee. 
1. An Accelerator Licensee may initially apply to be an Accelerator Cultivator, Accelerator 
Manufacturer or Accelerator Store and hold a single license. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 228 
2. After 180 days of demonstrated operations, an Accelerator Licensee may apply for 
additional accelerator licenses, which may include different accelerator license types. An 
Accelerator Licensee may not apply for more than one accelerator license until at least 
180 days of demonstrated operations. 
3. A Controlling Beneficial Owner who holds an accelerator license shall not have an 
Owner’s Interest in more than three of the same accelerator license type. No Controlling 
Beneficial Owner shall have an Owner’s Interest in more than nine total accelerator 
licenses. 
C. Accelerator-Endorsed Licensee Required Equity Assistance Proposal. 
1. An Accelerator-Endorsed Licensee must disclose its equity assistance proposal to the 
Division and to any prospective Social Equity Licensee pursuant to Rule 2-285 and these 
3-1100 Series Rules prior to entering any contractual agreements with an Accelerator 
Licensee. 
2. Required Information. An equity assistance proposal must detail the technical, 
compliance, and/or capital assistance the Accelerator-Endorsed Licensee intends to 
provide an Accelerator Licensee. All equity assistance proposals must, at a minimum, 
including the following: 
a. The types of assistance the Accelerator-Endorsed Licensee intends to provide, 
which may include but is not limited to, the following types of assistance: 
i. Accounting; 
ii. Business services (e.g. sales and marketing); 
iii. Financial or capital support; 
iv. Information technology support; 
v. Access to legal services from an attorney licensed in the state of 
Colorado; or 
vi. Regulatory compliance support. 
b. Whether the Accelerator-Endorsed Licensee intends to subcontract with any third 
parties to provide technical or compliance assistance, and the identity of the 
prospective third parties, if known; 
c. Any applicable timelines associated with the provisions of the assistance the 
Accelerator-Endorsed Licensee intends to provide; 
d. Whether the Accelerator-Endorsed Licensee intends to charge rent for a 
prospective Accelerator Licensee’s use of the premises, and the amount of rent 
and required deposits, if applicable; 
e. How the Accelerator-Endorsed Licensee plans to protect or minimize disruptions 
on a prospective Accelerator Licensee in the event of a change of Controlling 
Beneficial Owner of the Accelerator-Endorsed Licensee’s license; and 
f. Whether the Accelerator-Endorsed Licensee has been subject to any 
administrative action by the State Licensing Authority or the Local Jurisdiction 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 229 
within the preceding two years and, if so, whether there are any restrictions on 
the Licensee as a result of such administrative action. 
3. Voluntary Information. An equity assistance proposal may, but is not required to, include 
additional information about the Accelerator-Endorsed Licensee, including but not limited 
to the following: 
a. The Accelerator-Endorsed Licensee’s business objectives and organizational 
values; 
b. A description of the Accelerator-Endorsed Licensee’s work environment; 
c. Information regarding the Accelerator-Endorsed Licensee’s business profile, 
including company size, revenue, and distribution capabilities; 
d. Any educational or training assistance provided to the Accelerator Licensee in 
navigating human resources matters; and 
e. Any other information that may be useful to informing prospective Accelerator 
Licensees and determining compatibility between an Accelerator-Endorsed 
Licensee and Accelerator Licensee. 
4. Modification of Equity Assistance Proposal. Nothing in these rules shall preclude an 
Accelerator-Endorsed Licensee from amending or modifying its equity assistance 
proposal. The Accelerator-Endorsed Licensee shall submit the updated equity assistance 
proposal to the Division within 30 days of finalizing any such amendments or 
modifications. 
5. The Accelerator-Endorsed Licensee may request that a prospective Social Equity 
Licensee enter into a non-disclosure agreement prior to providing the prospective Social 
Equity Licensee a copy of the Accelerator-Endorsed Licensee’s equity assistance 
proposal in order to ensure the information remains confidential. 
D. Equity Partnership Agreement – General Requirements. Prior to hosting or offering technical 
and/or capital support to an Accelerator Licensee, an Accelerator-Endorsed Licensee must first 
enter into an equity partnership agreement with the Accelerator Licensee. In addition to any other 
requirements in Rules 3-1110 and 3-1115, an equity partnership agreement must include the 
following minimum requirements: 
1. The equity partnership agreement must be executed by both the Accelerator-Endorsed 
Licensee and the Accelerator Licensee. 
2. The executed equity partnership agreement must represent the full legal and business 
relationship between the Accelerator-Endorsed Licensee and Accelerator Licensee 
unless additional agreements are permitted or required pursuant to Rules 3-1110 or Rule 
3-1115. 
3. The executed equity partnership agreement shall at a minimum, include the following: 
a. A description of the types of technical, compliance, and/or capital assistance the 
Accelerator-Endorsed Licensee is providing to the Accelerator Licensee; 
b. The timeline associated with the assistance the Accelerator-Endorsed Licensee 
is providing; 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 230 
c. If the Accelerator-Endorsed Licensee is charging rent for the Accelerator 
Licensee’s use of the Licensed Premises, the rent amount, any required 
deposits, and length of lease; 
d. How the Accelerator-Endorsed Licensee will protect or minimize disruptions to 
the Accelerator Licensee in the event of a change of owner of the Accelerator-
Endorsed Licensee’s license; 
e. Conditions for amendments to the equity partnership agreement; and 
f. Conditions for dissolution of the equity partnership agreement. 
4. An Accelerator-Endorsed Licensee must provide technical, compliance, and/or capital 
assistance to an Accelerator Licensee pursuant to its equity partnership agreement with 
an Accelerator Licensee. An Accelerator-Endorsed Licensee may provide technical 
and/or compliance assistance to an Accelerator Licensee through third parties. However, 
an equity partnership agreement cannot require an Accelerator Licensee to receive such 
assistance from a specific provider unless permitted pursuant to Rule 3-1115. 
E. There shall not be any agreement(s) or contracts between the Accelerator-Endorsed Licensee 
and the Accelerator Licensee that are not disclosed to the Division. 
F. Dissolution of Business Relationship. If the business relationship between the Accelerator-
Endorsed Licensee and Accelerator Licensee dissolves, both parties must notify the Division 
within 10 days. The notification of dissolution must include the reasons for the dissolution of the 
business relationship between the Accelerator-Endorsed Licensee and Accelerator Licensee. 
1. The Accelerator Licensee will have until renewal of the Accelerator License to identify a 
new Accelerator-Endorsed Licensee or apply for a new Regulated Marijuana Business 
license unless this deadline is extended by the Division. The Division may waive or 
reduce the application and/or licensing fees affiliated with the application. However, the 
Accelerator Licensee cannot operate without a Licensed Premises or an executed and 
valid equity partnership agreement with an Accelerator-Endorsed Licensee. 
2. Upon notification of dissolution of the accelerator business relationship, the Division will 
determine whether the Accelerator-Endorsed Licensee retains the social equity leader 
designation for that calendar year. 
G. Additional Privileges for Accelerator-Endorsed Licensees. 
1. Social Equity Leader Designation. A Retail Marijuana Store, Retail Marijuana Cultivation 
Facility, or Retail Marijuana Products Manufacturer that is an Accelerator-Endorsed 
Licensee and that is operating under an equity partnership agreement with an 
Accelerator Licensee may be designated by the Division as a social equity leader for 
each year the Accelerator-Endorsed Licensee hosts an Accelerator Licensee on its 
premises. A social equity leader may use a logo or symbol created or approved by the 
Division to indicate its leadership status. The Accelerator-Endorsed Licensee may only 
use the social equity leader logo or symbol while the designation remains valid. 
2. Mitigation. The Division and the State Licensing Authority may consider a social equity 
leader designation as a mitigating factor when determining the initiation of administrative 
action or assessment of penalties. 
3. Compliance Assistance and Education Engagement. For an Accelerator-Endorsed 
Licensee operating under an equity partnership agreement with an Accelerator Licensee, 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 231 
the Division will conduct an on-site compliance assistance and education engagement 
with the Accelerator-Endorsed Licensee for purposes of supporting the Licensee’s 
activities as an Accelerator-Endorsed Licensee. 
4. Application and License Fee Exemptions. An Accelerator-Endorsed Licensee may submit 
a request to the State Licensing Authority for an exemption from application and license 
fees for a change of Controlling Beneficial Owner or change of location that is directly 
related to its participation in the accelerator program. 
a. The request for an exemption may be included with the submission of the 
application for which it is requesting an exemption from fees. The request for 
exemption must include any information demonstrating the application is related 
to its participation in the accelerator program, including but not limited to, the 
positive impact to the Accelerator Licensee. 
b. If a request for an exemption is denied, the Applicant shall submit required fees 
within 10 days from notice that the fee exemption request was denied. Failure to 
submit required fees may result in denial of the application. 
Basis and Purpose – 3-1110 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-
203(2)(aa), 44-10-310(2), and 44-10-311(2), C.R.S. The purpose of this rule is to establish requirements 
for Accelerator-Endorsed Licensees and Social Equity Licensees to participate in the accelerator 
program. This option is for the Accelerator-Endorsed Licensee and the Social Equity Licensee to have a 
mentor/apprentice type relationship pursuant to Rules 3-1105 and 3-1110. 
3-1110 – Accelerator Shared Premises 
A. Equity Assistance Plan – Additional Requirements. In addition to all equity assistance proposal 
requirements outlined in Rule 3-1105(C)(1), an Accelerator-Endorsed Licensee intending to share 
its Licensed Premises with an Accelerator Licensee must also include the following in tis equity 
assistance proposal: 
1. How the Accelerator-Endorsed Licensee will protect or minimize disruptions to a 
prospective Accelerator Licensee in the event of a change of location of the Accelerator-
Endorsed Licensee’s Licensed Premises; 
2. The extent to which the Accelerator-Endorsed Licensee will pro